[1] Maschmeyer G, Carratalà J, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients(allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)[J].Ann Oncol,2015,26(1):21-33.
[2] Kish MA. Infectious Diseases Society of America. Guide to development of practice guidelines[J].Clin Infect Dis,2001,32(6):851-854.
[3] Mühlethaler K, Bgli-Stuber K, Wasmer S,et al. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients[J]. Eur Respir J,2012,39(4): 971-978.
[4] Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of β-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis[J]. Clin Microbiol Infect, 2013,19(1): 39-49.
[5] Avni T, Levy I, Sprecher H, et al. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review[J]. J Clin Microbiol, 2012, 50(11): 3652-3658.
[6] Heng SC, Morrissey O, Chen SC ,et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis[J].Crit Rev Microbiol, 2015, 41(1):124-134.
[7] Marr KA, Laverdiere M, Gugel A, et al. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay[J]. Clin Infect Dis, 2005,40(12): 1762-1769.
[8] McCulloch E, Ramage G, Rajendran R, et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis[J]. J Clin Pathol, 2012,65(1): 83-86. |
